Skip to content
Thursday, November 19, 2026
Orbitspins Station

Zimbabwe Declines ‘Unbalanced’ US Healthcare Assistance Package Over Information Apprehensions

Medical funding illustration
The offered American financial assistance was intended for initiatives for treating and preventing HIV/Aids, TB, and malaria.

Zimbabwe has declined a major US healthcare agreement valued at $367m (£272m) over five years due to Washington's insistence on sensitive information.

The decision came to light after a internal memorandum from December was disclosed, which showed President Emmerson Mnangagwa deemed the arrangement was "unbalanced".

A government spokesman has since explained that the United States was seeking genetic material for research and commercial gain but refused to share the resulting advantages from any future vaccines.

"We must now begin the difficult and regrettable task of scaling back our health aid in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont publicly.

The US Embassy noted the United States had provided more than $1.9bn as health assistance to Zimbabwe during the past two decades.

A doctors' association in Zimbabwe has urged more negotiations to find a deal agreeable to both sides so the country's critical HIV programme can proceed.

Broader Context

This development comes after a comparable situation in Kenya, where a high court blocked a related health funding agreement following legal challenges were raised about the security of Kenyans' health data.

After returning to office recently, US President Donald Trump has slashed overseas assistance and shut down the US Agency for International Development (USAID).

The agency had overseen aid for the US government, but Trump stated its spending was "inefficient" and his government was seeking direct bilateral agreements to boost openness and responsibility.

According to reports, 16 African countries have to date agreed to these new agreements, constituting more than $18.3bn in new funding.

Specifics of the Rejected Deal

The money for Zimbabwe would have gone towards "HIV/Aids treatment and prevention, TB, malaria, healthcare for mothers and children, and preparing for epidemics".

"We are confident this collaboration might have yielded significant benefits for Zimbabwean communities, particularly the 1.2 million men, women and children currently on antiretroviral therapy via American-funded programmes," Tremont commented.

However, official spokesman Nick Mangwana argued the proposed deal was "asymmetrical".

"The proposal required Zimbabwe to provide its genetic material and health information over an extended period, without any equivalent promise of benefiting from any scientific breakthroughs – like new medicines or tests – that could result from that provided information," his statement read.

"Put simply, our country would supply the basic resources for medical research with no assurance that the resulting innovations would be accessible to our people if a future pandemic arise."

Sovereignty and Global Health

Mangwana further pointed out that the US's withdrawal from the World Health Organization (WHO) and its push of one-on-one deals were undermining systems already set up through the international organization.

The spokesperson gave as an example its Pandemic Benefit-Sharing scheme designed to manage potential pandemics.

"This mechanism is designed to ensure that when a nation provides its information, the benefits – such as vaccines and treatments – are distributed fairly, not commercialised exclusively by those with the funds to create them."

These objections over the US deal "are not meant as anti-American sentiment," he added.

"We are open to continued dialogue with our US partners on how future collaboration might be structured in a manner that respects the independence and dignity of each country."

Health Experts Response

Medical experts expressed it recognised the government's concerns, but urged that talks must proceed since much of the country's HIV programmes depended on external financing.

"In cases where specific concerns arise, such as those relating to data governance or implementation frameworks, these can frequently be resolved through detailed discussion and negotiated safeguards," it commented.

The halted deal highlights the complex tensions between receiving vital foreign assistance and protecting national sovereignty in an increasingly data-driven world.

About the author

Nancy Owens

Astrophysicist and science communicator, passionate about making space accessible to all.

Orbitspins Station

Type to search articles.